Cargando…
CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment
BACKGROUND: Definitive concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced non-small cell lung cancer (LANSCLC) patients, but the treatment response and survival outcomes varied among these patients. We aimed to identify pretreatment computed tomography-based radiomics...
Autores principales: | Chen, Nai-Bin, Xiong, Mai, Zhou, Rui, Zhou, Yin, Qiu, Bo, Luo, Yi-Feng, Zhou, Su, Chu, Chu, Li, Qi-Wen, Wang, Bin, Jiang, Hai-Hang, Guo, Jin-Yu, Peng, Kang-Qiang, Xie, Chuan-Miao, Liu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667605/ https://www.ncbi.nlm.nih.gov/pubmed/36384755 http://dx.doi.org/10.1186/s13014-022-02136-w |
Ejemplares similares
-
Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Chen, Nai-Bin, et al.
Publicado: (2020) -
A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer
por: Huo, LanQing, et al.
Publicado: (2023) -
Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
por: Liu, FangJie, et al.
Publicado: (2022) -
MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy
por: Siow, Tiing Yee, et al.
Publicado: (2022) -
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)